Article Text

Download PDFPDF
Immune infiltrates and PD-L1 expression in treatment-naïve acinar prostatic adenocarcinoma: an exploratory analysis

Footnotes

  • Handling editor Runjan Chetty.

  • Contributors MRD: designed study, acquired data, drafted and approved manuscript. EH, SKL, DV: acquired data, drafted and approved manuscript. BX: statistical analysis, drafted and approved manuscript.

  • Competing interests MRD has received compensation from Hoffman – La Roche and Astra Zeneca for participating on advisory boards and honoraria from Astra Zeneca. BX has received honoraria from Merck.

  • Patient consent Not required.

  • Ethics approval Approval for this research was obtained from the research ethics board of Sunnybrook Health Sciences Centre (REB 459–2016).

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Handling editor Runjan Chetty.

  • Contributors MRD: designed study, acquired data, drafted and approved manuscript. EH, SKL, DV: acquired data, drafted and approved manuscript. BX: statistical analysis, drafted and approved manuscript.

  • Competing interests MRD has received compensation from Hoffman – La Roche and Astra Zeneca for participating on advisory boards and honoraria from Astra Zeneca. BX has received honoraria from Merck.

  • Patient consent Not required.

  • Ethics approval Approval for this research was obtained from the research ethics board of Sunnybrook Health Sciences Centre (REB 459–2016).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.